ArticleInflammatory bowel diseases2024

Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.

Lauren V Collen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.